CD8A and neoplasm: Wang et al. discovered that Vγ9Vδ2 T cell activation enhanced the ability of CD8+ T cells to counter osteosarcoma, with CD8+ T cells managing osteosarcoma progression through the direct elimination of tumor cells (Wang S. et al., 2023).